Axiom Investors’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-47,580
Closed -$834K 143
2018
Q1
$834K Sell
47,580
-4,765
-9% -$83.5K 0.02% 143
2017
Q4
$1.29M Sell
52,345
-19,089
-27% -$471K 0.03% 131
2017
Q3
$1.84M Buy
71,434
+1,326
+2% +$34.2K 0.04% 123
2017
Q2
$1.9M Buy
70,108
+2,641
+4% +$71.6K 0.05% 122
2017
Q1
$2.01M Buy
+67,467
New +$2.01M 0.05% 120